Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group (Q44547436)
scientific article published in August 2003
Language:
Current Data About Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group
(P31) (Q13442814)
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

(P304) 3066-3071
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

(P407) (Q1860)

(P433) 16
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

(P478) 21
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

(P577) Friday, August 1, 2003
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

(P921) (Q16)

(Q974135)
(P887)

(Q29496)
(P887)

(Q976388)
(P887)

(P1433) (Q400292)
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

(P1476) "Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group" (language: en)
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

(P2093) Michael Crump
(P1545) 1
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

Dongsheng Tu
(P1545) 2
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

Lois Shepherd
(P1545) 3
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

Mark Levine
(P1545) 4
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

Vivien Bramwell
(P1545) 5
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

Kathleen Pritchard
(P1545) 6
(P248)
(P698) 12915595
(P813) Monday, December 4, 2017

other details
description scientific article published in August 2003

External Links
(P356) 10.1200/JCO.2003.08.137
(P698) 12915595